Skip to content

Author

A. S. Geraskina

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Evaluation of Radiation Safety of Radiopharmaceutical Based on 177Lu-Dota-PSMA in the Treatment of Metastatic Castration-Resistant Prostate Cancer

When treating patients diagnosed with metastatic castration-resistant prostate cancer with 177Lu-DOTA-PSMA, the absorbed dose in the red bone marrow may exceed the established safe limit of 2 Gy in a significant proportion of patients.

I. Khvostunov, V. Krylov, A. Shurinov et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.